MICHAEL RIZKALLA: Open Payments
NPI 1477717791 · BORDENTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 15 payments from 6 companies in 2025. Trend: 2023 $588 · 2024 $196 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Foundation Fusion Solutions, LLC | 2 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $106 |
| Boston Scientific Corporation | 4 | $85 |
| Forte Bio-Pharma LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $16 |
Products named: RELISTOR, General - Therapies, Infinion 16, General - Pain Management, PROLATE, Belbuca, MOVANTIK.
Industry payments across NJ — which companies pay providers there.
